A neurocognitive animal model dissociating between acute illness and remission periods of schizophrenia
Open accessThe DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Abstract
RationaleThe development and validation of animal models of the cognitive impairments of schizophrenia have remained challenging subjects.ObjectiveWe review evidence from a series of experiments concerning an animal model that dissociates between the disruption of attentional capacities during acute illness periods and the cognitive load-dependent impairments that characterize periods of remission. The model focuses on the long-term attentional consequences of an escalating-dosing pretreatment regimen with amphetamine (AMPH).ResultsAcute illness periods are modeled by the administration of AMPH challenges. Such challenges result in extensive impairments in attentional performance and the “freezing” of performance-associated cortical acetylcholine (ACh) release at pretask levels. During periods of remission (in the absence of AMPH challenges), AMPH-pretreated animals’ attentional performance is associated with abnormally high levels of performance-associated cortical ACh release, indicative of the elevated attentional effort required to maintain performance. Furthermore, and corresponding with clinical evidence, attentional performance during remission periods is exquisitely vulnerable to distractors, reflecting impaired top-down control and abnormalities in fronto–mesolimbic–basal forebrain circuitry. Finally, this animal model detects the moderately beneficial cognitive effects of low-dose treatment with haloperidol and clozapine that were observed in clinical studies.ConclusionsThe usefulness and limitations of this model for research on the neuronal mechanisms underlying the cognitive impairments in schizophrenia and for drug-finding efforts are discussed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Kapur, S. (2003) · American Journal of Psychiatry · doi:10.1176/appi.ajp.160.1.13 · Cited by 2,813 · cited 6×
“Low doses were defined, in accordance with Kapur (2003), as resulting in 50% D2 receptor occupancy.”
BackgroundInfluentialRobinson, T. E., & Becker, J. B. (1986) · Brain Research Reviews · doi:10.1016/0165-0173(86)90002-0 · Cited by 1,796
CENTRAL CHOLINERGIC SYSTEMS AND COGNITION
Everitt, B. J., & Robbins, T. W. (1997) · Annual Review of Psychology · doi:10.1146/annurev.psych.48.1.649 · Cited by 1,348 · cited 2×
“…system in general and the cortical cholinergic input system in particular is necessary for the performance of a wide range of attentional functions and capacities and attention-dependent learning (Everitt and Robbins 1997; Hasselmo and McGaughy 2004; Sarter et al. 2005a; McGaughy et al. 2000).”
BackgroundLocalization of a human system for sustained attention by positron emission tomography
Pardo, J. V., Fox, P. T., & Raichle, M. E. (1991) · Nature · doi:10.1038/349061a0 · Cited by 1,284
The cognitive neuroscience of sustained attention: where top-down meets bottom-up.
Sarter, M., Givens, B., & Bruno, J. P. (2001) · Brain Research Reviews · doi:10.1016/s0165-0173(01)00044-3 · Cited by 1,194 · cited 1×
“…by salient, fixed, spatially invariant targets and can be performed primarily via bottom-up processes [Mar et al. 1996; Mori et al. 1996; Gold et al. 2007; see Sarter et al. (2001) for a definition and discussion of bottom-up versus top-down mechanisms contributing to attentional performance].”
BackgroundSelf-citationBreier, A., Su, T.-P., Saunders, R., Carson, R. E., Kolachana, B. S., de Bartolomeis, A., Weinberger, D. R., Weisenfeld, N., Malhotra, A. K., Eckelman, W. C., et al. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.6.2569 · Cited by 1,154 · cited 1×
“…present in schizophrenic patients, including never-medicated schizophrenic patients (Strakowski et al. 1997), and has been associated specifically with acute psychotic disease periods (Breier et al. 1997; Abi-Dargham et al. 1998; Laruelle and Abi-Dargham 1999; Laruelle et al. 1999, Laruelle 2000).”
BackgroundSarter, M., Hasselmo, M. E., Bruno, J. P., & Givens, B. (2005) · Brain Research Reviews · doi:10.1016/j.brainresrev.2004.08.006 · Cited by 667
Self-citationPrefrontal Acetylcholine Release Controls Cue Detection on Multiple Timescales
Parikh, V., Kozak, R., Martinez, V., & Sarter, M. (2007) · Neuron · doi:10.1016/j.neuron.2007.08.025 · Cited by 623
Self-citationHasselmo, M. E., & McGaughy, J. (2004) · Progress in Brain Research · doi:10.1016/s0079-6123(03)45015-2 · Cited by 525 · cited 2×
“…system in general and the cortical cholinergic input system in particular is necessary for the performance of a wide range of attentional functions and capacities and attention-dependent learning (Everitt and Robbins 1997; Hasselmo and McGaughy 2004; Sarter et al. 2005a; McGaughy et al. 2000).”
BackgroundBaseline Neurocognitive Deficits in the CATIE Schizophrenia Trial
Keefe, R. S. E., Bilder, R. M., Harvey, P. D., Davis, S. M., Palmer, B. W., Gold, J. M., Meltzer, H. Y., Green, M. F., Miller, D. D., Canive, J. M., et al. (2006) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301072 · Cited by 472 · cited 1×
“…disruption of attention The administration of relatively low doses of typical and atypical antipsychotic drugs has been repeatedly shown to produce moderately beneficial cognitive effects in schizophrenic patients (Green et al. 2002; Keefe et al. 2004, 2006; Mishara and Goldberg 2004).”
Background
Cited by
Animal models of schizophrenia
Jones, C., Watson, D., & Fone, K. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01386.x · Cited by 771
From drugs to deprivation: A Bayesian framework for understanding models of psychosis
Corlett, P. R., Frith, C. D., & Fletcher, P. C. (2009) · Psychopharmacology · doi:10.1007/s00213-009-1561-0 · Cited by 367
“Animal models suggest that this may be due to changes in the morphology of dendritic spines in striatal medium spiny neurons (Waltz et al. 2007), altered expression of NMDA and AMPA receptors (Lu et al. 1997 ;L u and Wolf 1999) and changes in pre-frontal cholinergic function ( Sarter et al. 2005, 2008 ).”
BackgroundGlutamatergic model psychoses: prediction error, learning, and inference
Corlett, P. R., Honey, G. D., Krystal, J. H., & Fletcher, P. C. (2011) · Neuropsychopharmacology · doi:10.1038/npp.2010.163 · Cited by 229
Howe, W. M., Ji, J., Parikh, V., Williams, S., Mocaër, E., Trocmé-Thibierge, C., & Sarter, M. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2010.9 · Cited by 150
Watson, D. J., Loiseau, F., Ingallinesi, M., Millan, M. J., Marsden, C. A., & Fone, K. C. (2012) · Neuropsychopharmacology · doi:10.1038/npp.2011.254 · Cited by 151
Metadata
- Authors
- Sarter, M., Martinez, V., & Kozak, R.
- Venue
- Psychopharmacology
- Published
- 2008-07-10
- Volume
- 202
- Issue
- 1-3
- Pages
- 237-258
- ISSN
- 0033-3158 (ISSN-L)
- 1432-2072
- OpenAlex
- W2008398396
- Cited by
- 40
- References
- 24
- FWCI
- 4.39
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: A neurocognitive animal model dissociating between acute illness and remission periods of schizophrenia. https://app.cochat.ai/papers/10.1007/s00213-008-1216-6
- The paper
- Sarter, M., Martinez, V., & Kozak, R. (2009). A neurocognitive animal model dissociating between acute illness and remission periods of schizophrenia. Psychopharmacology. https://doi.org/10.1007/s00213-008-1216-6
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.